What is it about?
Detailed analysis of how Israel succeeds in controlling pharmaceutical expenditures and an analysis of how Canada might learn from the Israeli experience
Featured Image
Why is it important?
Pharmaceutical expenditures are a large and growing component of health spending in all countries. Many countries can learn from Israel's success in this area. Most of the lessons discussed in the article are not limited to Canada.
Perspectives
Happy to pursue similar cross-national learning exercises with colleagues from other countries - either with regard to pharma spending or regading other major topics in health policy.
Bruce Rosen
Myers-JDC-Brookdale Institute
Read the Original
This page is a summary of: Expanding Canadian Medicare to include a national pharmaceutical benefit while controlling expenditures: possible lessons from Israel, Health Economics Policy and Law, February 2018, Cambridge University Press,
DOI: 10.1017/s174413311700041x.
You can read the full text:
Contributors
The following have contributed to this page
